Table 2.
Distribution of combined attendance in cervical cancer prevention according to country of origin.
| Vaccinated | Vaccinated | Un-vaccinated | Un-vaccinated | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Screened |
Un-screened |
Screened |
Un-screened |
|||||||||||||||||
| (n; %col) | n | % row | (95% CI) | n | % row | (95% CI) | n | % row | (95% CI) | n | % row | (95% CI) | ||||||||
| Denmark (151,885) | 66,354 | 43.7% | (43.4% | - | 43.9%) | 57,798 | 38.1% | (37.8% | - | 38.3%) | 12,549 | 8.3% | (8.1% | - | 8.4%) | 15,184 | 10.0% | (9.8% | - | 10.1%) |
| MENA countries* (11,115) | ||||||||||||||||||||
| Turkey (3,849; 35%) | 557 | 14.5% | (13.4% | – | 15.6%) | 2,067 | 53.7% | (52.1% | – | 55.3%) | 184 | 4.8% | (4.1% | – | 5.5%) | 1,041 | 27.0% | (25.6% | – | 28.5%) |
| Iraq (1,566; 35%) | 240 | 15.3% | (13.6% | – | 17.2%) | 709 | 45.3% | (42.8% | – | 47.8%) | 115 | 7.3% | (6.1% | – | 8.7%) | 502 | 32.1% | (29.7% | – | 34.4%) |
| Lebanon(1,312; 12%) | 215 | 16.4% | (14.4% | – | 18.5%) | 670 | 51.1% | (48.3% | – | 53.8%) | 91 | 6.9% | (5.6% | – | 8.4%) | 336 | 25.6% | (23.3% | – | 28.1%) |
| Pakistan(1,086; 10%) | 101 | 9.3% | (7.6% | – | 11.9%) | 559 | 51.5% | (48.5% | – | 54.5%) | 38 | 3.5% | (2.5% | – | 4.8%) | 388 | 35.7% | (32.9% | – | 38.7%) |
| Afghanistan (956; 9%) | 114 | 11.9% | (9.9% | – | 14.1%) | 557 | 58.3% | (55.1% | – | 61.4%) | 39 | 4.1% | (2.9% | – | 5.5%) | 246 | 25.7% | (23.0% | – | 28.6%) |
| Somalia (734; 7%) | 52 | 7.1% | (5.3% | – | 9.2%) | 250 | 34.1% | (30.6% | – | 37.6%) | 52 | 7.1% | (5.4% | – | 9.2%) | 380 | 52.0% | (48.1% | – | 55.4%) |
| Iran (560; 5%) | 162 | 28.9% | (25.2% | – | 32.9%) | 265 | 47.3% | (43.1% | – | 51.6%) | 40 | 7.1% | (5.2% | – | 9.6%) | 93 | 16.6% | (13.6% | – | 20.0%) |
| Other MENA (574; 5%) | 79 | 13.8% | (11.1% | – | 16.9%) | 276 | 48.1% | (43.9% | – | 52.3%) | 47 | 8.2% | (6.1% | – | 10.7%) | 172 | 30.0% | (26.2% | – | 33.9%) |
| Morocco (478; 4%) | 62 | 13.0% | (10.1% | – | 16.3%) | 205 | 42.9% | (38.4% | – | 47.5%) | 27 | 5.6% | (3.8% | – | 8.1%) | 184 | 38.5% | (34.1% | – | 43.0%) |
*MENA countries with more than 450 observations are reported individually, while the remaining countries reported as “other MENA“
Time and place of the study: 1.6.2007 – 31.12.2016 in Denmark